信息搜索
信息关键字：药
  
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·华海药业（600521）1月9日主力资金净买入1190.08万元2023-1-10 7:49:53
·普祺医药副总经理刘东旭辞职2023-1-9 23:22:51
·亨迪药业：布洛芬片通过仿制药一致性评价有利于该产品市场销售2023-1-9 21:21:11
·辉瑞新冠药未进医保重挫代工厂股价在华本地生产仍在推进中2023-1-9 20:52:03
·广生堂：新冠药泰中定具有优越的抗新冠病毒疗效2023-1-9 19:41:41
·辉瑞新冠口服药医保谈判失败后要怎么买？或延长临时报销时限2023-1-9 19:36:48
·天宇股份：公司原料药磷酸西格列汀通过CDE审批2023-1-9 19:03:19
·迪哲医药：舒沃替尼与戈利昔替尼联合疗法获药物临床试验批准通知书2023-1-9 18:51:12
·特宝生物：获得人干扰素α2b喷雾剂药物临床试验批准通知书2023-1-9 17:55:43
·辉瑞新冠药医保没谈成这只A股开盘跌超8%！将生产仿制药？公司回应2023-1-9 17:29:48
·康缘药业：公司品种列入《新型冠状病毒肺炎诊疗方案（试行第十版）》2023-1-9 16:56:01
·新通药物周四再闯科创板 License-in模式何去何从2023-1-9 16:26:43
·红日药业：血必净注射液列入《新型冠状病毒感染诊疗方案（试行第十版）》2023-1-9 16:21:33
·刷屏！阿兹夫定卖到脱销？多家A股公司最新回应新冠药概念拉升2023-1-9 16:21:19
·启迪药业（000590）1月9日主力资金净卖出321.57万元2023-1-9 15:49:40
·仟源医药（300254）1月9日主力资金净卖出367.99万元2023-1-9 15:29:22
·东北制药被强制执行368万2023-1-9 15:25:21
·即将清仓！昆药集团原控股股东继续减持1896万股华润入驻能否带来新局面？2023-1-9 12:18:42
·中药材市场热度不减！清热解毒类“退烧”止咳化痰类需求上升2023-1-9 12:01:33
·共同药业（300966）1月6日主力资金净卖出1302.61万元2023-1-9 11:45:07

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]